imcivree - setmelanotide solution
(Setmelanotide)Rhythm Pharmaceuticals, Inc
Usage: Imcivree reduces excess body weight in adults and children aged 2+ with Bardet-Biedl syndrome or POMC, PCSK1, or LEPR deficiency, and in patients aged 4+ with acquired hypothalamic obesity. Not indicated for general obesity or other genetic syndromes.